Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine

Clinical trial NCT05768126 · UNKNOWN

Trial details

NCT number: NCT05768126
Sponsor: UMC Utrecht
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2021-09-29
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.